Citation

J. Brajtburg, William G. Powderly, M.D., George S. Kobayashi, Gerald Medoff, M.D. Amphotericin B: delivery systems. Antimicrobial Agents and Chemotherapy. 1990 Mar 01; 34(3):381-4.

Citation

Martin Bryant, Lee Ratner, M.D., Ph.D. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proceedings of the National Academy of Sciences of the United States of America. 1990 Jan 01; 87(2):523-7.

Citation

David B. Clifford, M.D., Robert G. Jacoby, J. Philip Miller, Warren R. Seyfried, Ph.D., Meridith Glicksman, M.S. Neuropsychometric performance of asymptomatic HIV-infected subjects. AIDS. 1990 Aug 01; 4(8):767-74.

Citation

W. Claiborne Dunagan. Mycobacterial infection and HIV disease. Missouri Medicine. 1990 Feb 01; 87(2):79-81.

Citation

Margaret A. Fischl, M.D., Douglas D. Richman, M.D., Nellie I. Hansen, M.P.H., Ann C. Collier, M.D., John T. Carey, M.D., Michael F. Para, M.D., W. David Hardy, M.D., Raphael Dolin, M.D., William G. Powderly, M.D., J. Davis Allan, Jr., M.D., Brian Wong, M.D., Thomas C. Merigan, Jr., M.D., Vincent J. McAuliffe, M.D., Newton E. Hyslop, Jr., M.D., Frank S. Rhame, M.D., Henry H. Balfour, Jr., M.D., Stephen A. Spector, M.D., Paul Volberding, M.D., Carla Pettinelli, M.D., Ph.D., James Anderson, Ph.D. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. Annals of Internal Medicine. 1990 May 15; 112(10):727-37.

Citation

John S. Lambert, M.D., Mindell Seidlin, M.D., Richard C. Reichman, M.D., Carol S. Plank, R.N., Maura Laverty, R.N., Gene D. Morse, Pharm.D., Catherine Knupp, D.V.M., Colin McLaren, Ph.D., Carla Pettinelli, M.D., Ph.D., Fred T. Valentine, M.D., Raphael Dolin, M.D. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial. New England Journal of Medicine. 1990 May 10; 322(19):1333-40.

Citation

Brendan Larder, Ph.D., Bruce Chesebro, Douglas D. Richman, M.D. Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Antimicrobial Agents and Chemotherapy. 1990 Mar 01; 34(3):436-41.

Citation

Ronald T. Mitsuyasu, M.D. Hematopoietic growth factors in the treatment of patients with HIV infection. Biotherapy. 1990 Jan 01; 2(2):173-81.

Citation

James R. Munis, Douglas D. Richman, M.D., Richard S. Kornbluth. Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide. Journal of Clinical Investigation. 1990 Feb 01; 85(2):591-6.

Citation

S. Peglow, Alan G. Smulian, Michael J. Linke, C. L. Pogue, John P. Phair, M.D., Jonathan W. M. Gold, M.D., Daniel Armstrong, Ph.D., Peter D. Walzer, M.D. Serologic responses to Pneumocystis carinii antigens in health and disease. Journal of Infectious Diseases. 1990 Feb 01; 161(2):296-306.